Clinical Trials Directory

Trials / Unknown

UnknownNCT03404414

Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT

Detection of Functioning Pituitary Microadenoma With Inconclusive MRI Findings: PET/MRI Versus PET/CT

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a prospective case-control study to compare the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas.A single dose of 370 Mega-Becquerel (MBq) 18F-FDG will be injected intravenously.Visual and semiquantitative method will be used to assess the PET/MRI and PET/CT images.

Detailed description

Magnetic resonance imaging (MRI) may be insufficient to locate functioning pituitary microadenoma.This study compared the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas in patients with inconclusive conventional MRI findings. Trans-sphenoidal adenomectomy was performed within 2 weeks of imaging.The PET/CT and PET/MRI findings and tracer uptake levels were correlated with the surgical findings and pathological results.

Conditions

Interventions

TypeNameDescription
DRUG18F-FDGSingle-dose 18F-FDG were injected into the patients before the PET/MR or PET/CT scans. patients before the PET/CT scans

Timeline

Start date
2013-02-01
Primary completion
2018-11-01
Completion
2018-11-01
First posted
2018-01-19
Last updated
2018-01-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03404414. Inclusion in this directory is not an endorsement.